loadpatents
name:-0.02118706703186
name:-0.014074087142944
name:-0.0027461051940918
Peel; Michael Robert Patent Filings

Peel; Michael Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peel; Michael Robert.The latest application filed is for "cyclosporin analog and use thereof".

Company Profile
0.12.16
  • Peel; Michael Robert - Babraham Cambridgeshire GB
  • Peel; Michael Robert - Research Triangle Park NC US
  • PEEL; Michael Robert - Chapel Hill NC
  • Peel; Michael Robert - Durham NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cyclosporin Analog And Use Thereof
App 20220079139 - Mak; Ching Pong ;   et al.
2022-03-17
Macrocyclic peptides
Grant 9,090,671 - Li , et al. July 28, 2
2015-07-28
Antiviral Macrocycles
App 20140213508 - Li; Keqiang ;   et al.
2014-07-31
Macrocycles
App 20140212381 - Li; Keqiang ;   et al.
2014-07-31
Macrocycles
Grant 8,536,114 - Li , et al. September 17, 2
2013-09-17
Novel Cyclic Peptides
App 20110144005 - Li; Keqiang ;   et al.
2011-06-16
Novel Macrocycles
App 20100173836 - Li; Keqiang ;   et al.
2010-07-08
Novel Macrocyclic Peptides
App 20090312300 - Li; Keqiang ;   et al.
2009-12-17
Novel Cyclic Peptides
App 20090306033 - Li; Keqiang ;   et al.
2009-12-10
Pharmaceutical Compositions
App 20080255038 - Hopkins; Samuel Earl ;   et al.
2008-10-16
Pyrazolopyridinyl pyridine
App 20070287721 - Boyd; F. Leslie ;   et al.
2007-12-13
Pyrazolopyridazine derivatives
Grant 7,279,473 - Badiang , et al. October 9, 2
2007-10-09
Chemical Compounds
App 20070142437 - Brown; Matthew Lee ;   et al.
2007-06-21
1,3-Oxazole compounds for the treatment of cancer
Grant 7,189,712 - Brown , et al. March 13, 2
2007-03-13
Fused pyrazole derivatives being protein kinase inhibitors
Grant 7,166,597 - Alberti , et al. January 23, 2
2007-01-23
Pyrazolopyridinyl pyrimidine therapeutic compounds
Grant 7,163,940 - Boyd , et al. January 16, 2
2007-01-16
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
Grant 7,109,209 - Alberti , et al. September 19, 2
2006-09-19
Pyralopyridines, process for their preparation and use as therapeutic compounds
Grant 7,034,030 - Alberti , et al. April 25, 2
2006-04-25
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
App 20060058319 - Alberti; Michael John ;   et al.
2006-03-16
Chemical compounds
App 20050288515 - Brown, Matthew Lee ;   et al.
2005-12-29
Oxindole derivatives
App 20050282810 - Harris, Philip Anthony ;   et al.
2005-12-22
Oxindole derivatives
Grant 6,964,977 - Harris , et al. November 15, 2
2005-11-15
Pyrazolopyridazine derivatves
App 20050090507 - Badiang, Jennifer G ;   et al.
2005-04-28
Pyralopyridines, process for their preparation and use as therapeutic compounds
App 20050059677 - Alberti, Michael John ;   et al.
2005-03-17
Oxindole derivatives
App 20030225090 - Harris, Philip Anthony ;   et al.
2003-12-04
Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
Grant 6,268,391 - Dickerson , et al. July 31, 2
2001-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed